Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ritika Dutta

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Molecular Genetics and Metabolism|July 7, 2016
CBP/p300 acetyltransferase activity in hematologic malignanciesRitika Dutta, Bruce Tiu, Kathleen M Sakamoto
Nature Cancer|May 29, 2023
Understanding inequities in precision oncology diagnosticsRitika Dutta, Mounica Vallurupalli, Quinn McVeigh, et al.
Science Translational Medicine|April 10, 2020
IL-6 blockade reverses bone marrow failure induced by human acute myeloid leukemiaTian Yi Zhang, Ritika Dutta, Brooks Benard, et al.
American Journal of Hematology|August 4, 2020
Improved outcomes of octogenarians and nonagenarians with acute myeloid leukemia in the era of novel therapiesMark Y Jeng, Ritika Dutta, Irena T Tan, et al.
Journal of Medical Case Reports|March 28, 2021
Epstein-Barr virus-positive lymphoproliferative disorder manifesting as pulmonary disease in a patient with acute myeloid leukemia: a case reportRitika Dutta, Susanna Y Miao, Paul Phan, et al.
JCO Oncology Practice|April 7, 2021
Financial Toxicity of Cancer Care: An Analysis of Financial Burden in Three Distinct Health Care SystemsDivya A Parikh, Meera Ragavan, Ritika Dutta, et al.
Leukemia & Lymphoma|June 17, 2020
Venetoclax and hypomethylating agent therapy in high risk myelodysplastic syndromes: a retrospective evaluation of a real-world experienceArmon Azizi, Asiri Ediriwickrema, Ritika Dutta, et al.
The Journal of Clinical Investigation|January 3, 2020
Enasidenib drives human erythroid differentiation independently of isocitrate dehydrogenase 2Ritika Dutta, Tian Yi Zhang, Thomas Köhnke, et al.
Oncotarget|February 4, 2016
Small molecule screen for inhibitors of expression from canonical CREB response element-containing promotersBryan Mitton, Katie Hsu, Ritika Dutta, et al.
Oncotarget|July 9, 2020
RSK inhibitor BI-D1870 inhibits acute myeloid leukemia cell proliferation by targeting mitotic exitHee-Don Chae, Ritika Dutta, Bruce Tiu, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Molecular Genetics and Metabolism|July 7, 2016
CBP/p300 acetyltransferase activity in hematologic malignanciesRitika Dutta, Bruce Tiu, Kathleen M Sakamoto
Nature Cancer|May 29, 2023
Understanding inequities in precision oncology diagnosticsRitika Dutta, Mounica Vallurupalli, Quinn McVeigh, et al.
Science Translational Medicine|April 10, 2020
IL-6 blockade reverses bone marrow failure induced by human acute myeloid leukemiaTian Yi Zhang, Ritika Dutta, Brooks Benard, et al.
American Journal of Hematology|August 4, 2020
Improved outcomes of octogenarians and nonagenarians with acute myeloid leukemia in the era of novel therapiesMark Y Jeng, Ritika Dutta, Irena T Tan, et al.
Journal of Medical Case Reports|March 28, 2021
Epstein-Barr virus-positive lymphoproliferative disorder manifesting as pulmonary disease in a patient with acute myeloid leukemia: a case reportRitika Dutta, Susanna Y Miao, Paul Phan, et al.
JCO Oncology Practice|April 7, 2021
Financial Toxicity of Cancer Care: An Analysis of Financial Burden in Three Distinct Health Care SystemsDivya A Parikh, Meera Ragavan, Ritika Dutta, et al.
Leukemia & Lymphoma|June 17, 2020
Venetoclax and hypomethylating agent therapy in high risk myelodysplastic syndromes: a retrospective evaluation of a real-world experienceArmon Azizi, Asiri Ediriwickrema, Ritika Dutta, et al.
The Journal of Clinical Investigation|January 3, 2020
Enasidenib drives human erythroid differentiation independently of isocitrate dehydrogenase 2Ritika Dutta, Tian Yi Zhang, Thomas Köhnke, et al.
Oncotarget|February 4, 2016
Small molecule screen for inhibitors of expression from canonical CREB response element-containing promotersBryan Mitton, Katie Hsu, Ritika Dutta, et al.
Oncotarget|July 9, 2020
RSK inhibitor BI-D1870 inhibits acute myeloid leukemia cell proliferation by targeting mitotic exitHee-Don Chae, Ritika Dutta, Bruce Tiu, et al.
Pageof 2